1887

Abstract

A recombinant live vector vaccine was produced by insertion of cDNA encoding the structural proteins (P1) of foot-and-mouth disease virus (FMDV) into a replication-competent human adenovirus type 5 vaccine strain (Ad5 wt). Groups of cattle (n = 3) were immunized twice, by the subcutaneous and/or intranasal routes, with either the Ad5 wt vaccine or with the recombinant FMDV Ad5-P1 vaccine. All animals were challenged by intranasal instillation of FMDV 4 weeks after the second immunizations. In the absence of a detectable antibody response to FMDV, significant protection against viral challenge was seen in all of the animals immunized twice by the subcutaneous route with the recombinant vaccine. The observed partial protection against clinical disease was not associated with a reduction in titre of persistent FMDV infections in the oropharynx of challenged cattle.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-3-671
1999-03-01
2022-08-12
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/3/0800671a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-3-671&mimeType=html&fmt=ahah

References

  1. Abrams C. C., King A. M., Belsham G. J. 1995; Assembly of foot- and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. Journal of General Virology 76:3089–3098
    [Google Scholar]
  2. Babiuk L. A., van Drunen Littel-van den Hurk S., Tikoo S. K., Lewis P. J., Liang X. 1996; Novel viral vaccines for livestock. Veterinary Immunology and Immunopathology 54:355–363
    [Google Scholar]
  3. Barnett P. V., Pullen L., Staple R. F., Lee L. J., Butcher R., Parkinson D., Doel T. R. 1996; A protective anti-peptide antibody against the immunodominant site of the A Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence. Journal of General Virology 77:1011–1018
    [Google Scholar]
  4. Barteling S. J., Vreeswijk J. 1991; Developments in foot-and-mouth disease vaccines. Vaccine 9:75–88
    [Google Scholar]
  5. Bett A. J., Prevec L., Graham F. L. 1993; Packaging capacity and stability of human adenovirus type 5 vectors. Journal of Virology 67:5911–5921
    [Google Scholar]
  6. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A. 1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30–33
    [Google Scholar]
  7. Brown F. 1988; Use of peptides for immunization against foot-and-mouth disease. Vaccine 6:180–182
    [Google Scholar]
  8. Brown F. 1995; Antibody recognition and neutralization of foot-and-mouth disease virus. Seminars in Virology 6:243–248
    [Google Scholar]
  9. Chengalvala M. V., Bhat B. M., Bhat R., Lubeck M. D., Mizutani S., Davis A. R., Hung P. P. 1994; Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs. Journal of General Virology 75:125–131
    [Google Scholar]
  10. Collen T. 1994; Foot-and-mouth disease (Aphthovirus): viral T cell epitopes. In Cell-mediated Immunity in Ruminants pp 173–197 Edited by Goddeevis B. M. L., Morrison I. Boca Raton, FL: CRC Press;
    [Google Scholar]
  11. Doel T. R., Williams L., Barnett P. V. 1994; Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 12:592–600
    [Google Scholar]
  12. Domingo E., Davila M., Ortin J. 1980; Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth disease virus. Gene 11:333–346
    [Google Scholar]
  13. Ertl H. C., Xiang Z. 1996; Novel vaccine approaches. Journal of Immunology 156:3579–3582
    [Google Scholar]
  14. Falk M. M., Grigera P. R., Bergmann I. E., Zibert A., Multhaup G., Beck E. 1990; Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. Journal of Virology 64:748–756
    [Google Scholar]
  15. Ferris N. P., Dawson M. 1988; Routine application of enzyme linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases. Veterinary Microbiology 8:249–256
    [Google Scholar]
  16. Gallichan W. S., Johnson D. C., Graham F. L., Rosenthal K. L. 1993; Mucosal immunity and protection after intranasal immunisation with recombinant adenovirus expressing herpes simplex virus glycoprotein B. Journal of Infectious Diseases 168:622–629
    [Google Scholar]
  17. Gallichan W. S., Johnson D. C., Graham F. L., Rosenthal K. L. 1995; Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus. Advances in Experimental Medical Biology 371B:1581–1585
    [Google Scholar]
  18. Gaydos C. A., Gaydos J. C. 1995; Adenovirus vaccines in the U. S. military. Military Medicine 160:300–304
    [Google Scholar]
  19. Golding S. M., Hedger R. S., Talbot P. 1976; Radial immune diffusion and serum-neutralization techniques for the assay of antibodies to swine vesicular disease. Research in Veterinary Science 20:142–147
    [Google Scholar]
  20. Graham F. L., Prevec L. 1991; Manipulation of adenovirus vectors. Methods in Molecular Biology 7:109–128
    [Google Scholar]
  21. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
  22. Graham F. L., Prevec L., Schneider M., Ghosh-Choudhury G., McDermott M., Johnson D. C. 1988; Cloning and expression of glycoprotein genes in human adenovirus vectors. In Technological Advances in Vaccine Development pp 243–253 Edited by Laskey E. L. New York: A. R. Liss;
    [Google Scholar]
  23. Hitt M., Bett A. J., Addison C. L., Prevec L., Graham F. L. 1995; Techniques for human adenovirus vector construction and characterization. Methods in Molecular Genetics 7:13–30
    [Google Scholar]
  24. Hsu K. H., Lubeck M. D., Bhat B. M., Bhat R. A., Kostek B., Selling B. H., Mizutani S., Davis A. R., Hung P. P. 1994; Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model. Vaccine 12:607–612
    [Google Scholar]
  25. Kadoi K. 1997; Beneficial use of inactivated porcine adenovirus vaccine and antibody response of young pigs. New Microbiology 20:89–91
    [Google Scholar]
  26. Lubeck M. D., Natuk R. J., Chengalvala M., Chanda P. K., Murthy K. K., Murthy S., Mizutani S., Lee S. G., Wade M. S., Bhat B. M. and others 1994; Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Research in Human Retroviruses 10:1443–1449 [Erratum 11, 189.]
    [Google Scholar]
  27. Martinez-Salas E., Domingo E. 1995; Effect ofthe expression of the aphthovirus protease 3C on viral infection and gene expression. Virology 212:111–120
    [Google Scholar]
  28. Mateu M. G. 1995; Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Research 38:1–24
    [Google Scholar]
  29. Mateu M. G., Martinez M. A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E. 1990; A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. Journal of General Virology 71:629–637
    [Google Scholar]
  30. Mittal S. K., McDermott M. R., Johnson D. C., Prevec L., Graham F. L. 1993; Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Research 28:67–90
    [Google Scholar]
  31. Mittal S. K., Papp Z., Tikoo S. K., Baca-Estrada M. E., Yoo D., Benko M., Babiuk L. A. 1996; Induction of systemic and mucosal immune responses in cotton rats immunised with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology 222:299–309
    [Google Scholar]
  32. Pereira H. G. 1981; Foot-and-mouth disease. In Virus Diseases of Food Animals pp 333–363 Edited by Gibbs E. P. J. New York: Academic Press;
    [Google Scholar]
  33. Porter A. G. 1993; Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. Journal of Virology 67:6917–6921
    [Google Scholar]
  34. Prevec L., Schneider M., Rosenthal K. L., Belbeck L. W., Derbyshire J. B., Graham F. L. 1989; Use of human adenovirus-based vectors for antigen expression in animals. JournalofGeneral Virology 70:429–434 [Corrigendum 70, 2539.]
    [Google Scholar]
  35. Randrianarison-Jewtoukoff V., Perricaudet M. 1995; Recombinant adenoviruses as vaccines. Biologicals 23:145–157
    [Google Scholar]
  36. Rodriguez A., Saiz J. C., Novella I. S., Andreu D., Sobrino F. 1994; Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Virology 205:24–33
    [Google Scholar]
  37. Roeder P. L., Le Blanc Smith P. M. 1987; Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis. Research in Veterinary Science 43:225–232
    [Google Scholar]
  38. Rose J. K., Buonocore L., Whitt A. 1991; A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. BioTechniques 10:520–525
    [Google Scholar]
  39. Saiz J. C., Cairo J., Medina M., Zuidema D., Abrams C., Belsham G.J., Domingo E., Vlak J. M. 1994; Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. Journal of Virology 68:4557–4564
    [Google Scholar]
  40. Salt J. S., Mulcahy G., Kitching R. P. 1996; Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier" and "non-carrier" cattle. Epidemiology and Infection 117:349–360
    [Google Scholar]
  41. Sanz-Parra A., Blasco R., Sobrino F., Ley V. 1998; Analysis of the B and T cell response in guinea pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins. Archives of Virology 143:389–398
    [Google Scholar]
  42. Snowdon W. A. 1966; Growth of foot-and-mouth disease virus in monolayer cultures of calf thyroid cells. Nature 210:1079–1080
    [Google Scholar]
  43. Strohmaier K., Franze R., Adam K. H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
  44. Sutmoller P., Gaggero A. 1965; Foot-and mouth diseases carriers. Veterinary Record 77:968–969
    [Google Scholar]
  45. Taboga O., Tami C., Carrillo E., Nunez J. I., Rodriguez A., Saiz J. C., Blanco E., Valero M. L., Roig X., Camarero J. A., Andreu D., Mateu M. G., Giralt E., Domingo E., Sobrino F., Palma E. L. 1997; A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. Journal of Virology 71:2606–2614
    [Google Scholar]
  46. Torres J. M., Sanchez C., Sune C., Smerdou C., Prevec L., Graham F., Enjuanes L. 1995; Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 213:503–516
    [Google Scholar]
  47. Torres J. M., Alonso C., Ortega A., Mittal S., Graham F., Enjuanes L. 1996; Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. Journal of Virology 70:3770–3780
    [Google Scholar]
  48. Usherwood E. J., Nash A. A. 1995; Lymphocyte recognition of picornaviruses. Journal of General Virology 76:499–508
    [Google Scholar]
  49. van Lierop M. J., Wagenaar J. P., van Noort J. M., Hensen E. J. 1995; Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. Journal of Virology 69:4511–4514
    [Google Scholar]
  50. Xiang Z. Q., Yang Y., Wilson J. M., Ertl H. C. 1996; A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220–227
    [Google Scholar]
  51. Yarosh O. K., Wandeler A. I., Graham F. L., Campbell J. B., Prevec L. 1996; Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 14:1257–1264
    [Google Scholar]
  52. Zinkernagel R. M. 1996; Immunology taught by viruses. Science 271:173–178
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-3-671
Loading
/content/journal/jgv/10.1099/0022-1317-80-3-671
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error